Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000790750 | SCV000332228 | pathogenic | not provided | 2015-06-19 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000790750 | SCV001374288 | pathogenic | not provided | 2019-09-10 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in LIFR are known to be pathogenic (PMID: 14740318). This variant has been observed in several individuals affected with Stuve-Wiedemann syndrome (PMID: 14740318). ClinVar contains an entry for this variant (Variation ID: 281444). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Glu219Glyfs*3) in the LIFR gene. It is expected to result in an absent or disrupted protein product. |
Gene |
RCV000790750 | SCV002008998 | pathogenic | not provided | 2022-11-08 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 14740318) |
OMIM | RCV000348821 | SCV000035810 | pathogenic | Stuve-Wiedemann syndrome | 2022-02-16 | no assertion criteria provided | literature only | |
Department Of Genetics, |
RCV000761445 | SCV000891529 | pathogenic | Familial hemophagocytic lymphohistiocytosis 2 | 2017-12-30 | no assertion criteria provided | curation | |
Clinical Laboratory Sciences Program |
RCV003326396 | SCV003927818 | pathogenic | Stüve-Wiedemann syndrome 1 | 2023-04-01 | no assertion criteria provided | clinical testing |